Friday, September 16, 2016

Travatan Z


Travatan Z is a brand name of travoprost ophthalmic, approved by the FDA in the following formulation(s):


TRAVATAN Z (travoprost - solution/drops; ophthalmic)



  • Manufacturer: ALCON PHARMS LTD

    Approval date: September 21, 2006

    Strength(s): 0.004% [RLD]

Has a generic version of Travatan Z been approved?


No. There is currently no therapeutically equivalent version of Travatan Z available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Travatan Z. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
    Patent 5,510,383
    Issued: April 23, 1996
    Inventor(s): Bishop; John E. & DeSantis, Jr.; Louis & Sallee; Verney L.
    Assignee(s): Alcon Laboratories, Inc.
    Disclosed is the use of cloprostenol, fluprostenol, and their pharmaceutically acceptable salts and esters for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
    Patent expiration dates:

    • August 3, 2013
      ✓ 
      Patent use: METHOD FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION
      ✓ 
      Drug product




  • Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
    Patent 5,889,052
    Issued: March 30, 1999
    Inventor(s): Klimko; Peter G. & Bishop; John E. & Sallee; Verney L. & Zinke; Paul W.
    Assignee(s): Alcon Laboraties, Inc.
    Disclosed is the use of cloprostenol and fluprostenol analogues for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
    Patent expiration dates:

    • December 2, 2014
      ✓ 
      Patent use: METHOD FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION
      ✓ 
      Drug product




  • Use of borate-polyol complexes in ophthalmic compositions
    Patent 6,503,497
    Issued: January 7, 2003
    Inventor(s): Masood; Chowhan & Nissanke L.; Dassanayake
    Assignee(s): Alcon Manufacturing, Ltd.
    Water-soluble borate-polyol complexes are useful as buffers and/or antimicrobials in aqueous ophthalmic compositions, including those containing polyvinyl alcohol. These compositions have greater antimicrobial activity than comparable compositions containing typical borate buffers and unexpectedly increase the antimicrobial efficacy of other antimicrobial agents when used in combination. In addition, use of the boratepolyol complexes avoids the incompatibility problem typically associated with the combination of borate buffer and polyvinyl alcohol; therefore, the compositions disclosed herein may also contain polyvinyl alcohol.
    Patent expiration dates:

    • May 6, 2012
      ✓ 
      Drug product




  • Use of borate-polyol complexes in ophthalmic compositions
    Patent 6,849,253
    Issued: February 1, 2005
    Inventor(s): Chowhan; Masood & Dassanayake; Nissanke L.
    Assignee(s): Alcon Manufacturing, Ltd.
    Water-soluble borate-polyol complexes are useful as buffers and/or antimicrobials in aqueous ophthalmic compositions, including those containing polyvinyl alcohol. These compositions have greater antimicrobial activity than comparable compositions containing typical borate buffers and unexpectedly increase the antimicrobial efficacy of other antimicrobial agents when used in combination. In addition, use of the borate-polyol complexes avoids the incompatibility problem typically associated with the combination of borate buffer and polyvinyl alcohol; therefore, the compositions disclosed herein may also contain polyvinyl alcohol.
    Patent expiration dates:

    • May 6, 2012
      ✓ 
      Drug product



See also...

  • Travatan Z Consumer Information (Drugs.com)
  • Travatan Z Drops Consumer Information (Wolters Kluwer)
  • Travatan Z Consumer Information (Cerner Multum)
  • Travoprost Drops Consumer Information (Wolters Kluwer)
  • Travoprost ophthalmic Consumer Information (Cerner Multum)
  • Travoprost Ophthalmic Advanced Consumer Information (Micromedex)
  • Travoprost AHFS DI Monographs (ASHP)

No comments:

Post a Comment